CIK 0002078008
- Non-accelerated filer
Versigent PLC
Sign in to watch- Ticker
- VGNT
- Exchange
- NYSE
- Industry
- Motor Vehicle Parts & Accessories
- FY end
- Dec 31
- Incorporated
- Jersey
- Entity type
- Operating
- EIN
- 981868085
- Phone
- +1 248-285-1238
- Business address
- SPITALSTRASSE 5, SCHAFFHAUSEN, Switzerland, 8200
- Former names
- Versigent Ltd, Cyprium Holdings Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,065,510
- in 2 filings, $10.1M under 10b5-1 plans
Net −$10,065,510. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Vinci Sharon Chief People Officer | Exercise or conversion | +28 | 61,502 | ||
| 2026-11-13 | Vinci Sharon Chief People Officer | Shares withheld for taxes | −10 | $42.19 | $422 | 61,492 |
| 2026-11-13 | Vinci Sharon Chief People Officer | Shares withheld for taxes | −3,646 | $42.19 | $154K | 57,846 |
| 2026-11-13 | Vinci Sharon Chief People Officer | Exercise or conversion · Dividend Equivalent Rights | +28 | 144.63 | ||
| 2026-11-13 | Ostermann Douglas R Chief Financial Officer | Exercise or conversion | +119 | 169,661 | ||
| 2026-11-13 | Ostermann Douglas R Chief Financial Officer | Shares withheld for taxes | −52 | $42.19 | $2K | 169,609 |
| 2026-11-13 | Ostermann Douglas R Chief Financial Officer | Shares withheld for taxes | −18,328 | $42.19 | $773K | 151,281 |
| 2026-11-13 | Ostermann Douglas R Chief Financial Officer | Exercise or conversion · Dividend Equivalent Rights | +119 | 361.6 | ||
| 2026-10-08 | CLARK KEVIN P Director | Sale 10b5-1 | −45,085 | $44.33 | $2.0M | 30,247 |
| 2026-10-08 | CLARK KEVIN P Director | Sale 10b5-1 | −2,676 | $44.88 | $120K | 27,571 |
| 2026-10-07 | CLARK KEVIN P Director | Sale 10b5-1 | −43,692 | $44.90 | $2.0M | 81,157 |
| 2026-10-07 | CLARK KEVIN P Director | Sale 10b5-1 | −5,331 | $45.68 | $244K | 75,826 |
| 2026-10-07 | CLARK KEVIN P Director | Sale 10b5-1 | −494 | $46.43 | $23K | 75,332 |
| 2026-09-18 | Alving Amy E Director | Grant or award · Dividend Equivalent Rights | +14.65 | 14.65 | ||
| 2026-09-18 | CLARK KEVIN P Director | Grant or award · Dividend Equivalent Rights | +14.65 | 14.65 | ||
| 2026-09-18 | Vinci Sharon Chief People Officer | Grant or award · Dividend Equivalent Rights | +172.63 | 172.63 | ||
| 2026-09-18 | CELIAN JASON Chief Accounting Officer | Grant or award · Dividend Equivalent Rights | +25.75 | 25.75 | ||
| 2026-09-18 | Ostermann Douglas R Chief Financial Officer | Grant or award · Dividend Equivalent Rights | +480.6 | 480.6 | ||
| 2026-09-18 | Liotine Joseph T. CEO and Director | Grant or award · Dividend Equivalent Rights | +489.23 | 489.23 | ||
| 2026-09-18 | Cerepak Brad M Director | Grant or award · Dividend Equivalent Rights | +14.65 | 14.65 |
Page 1 of 3 · 48 trades